Journal
Journal of Biological Chemistry
Publication Date
12-1-2022
Volume
298
Issue
12
First Page
102700
Document Type
Open Access Publication
DOI
10.1016/j.jbc.2022.102700
Rights and Permissions
Donahue K, Xie H, Li M, Gao A, Ma M, Wang Y, Tipton R, Semanik N, Primeau T, Li S, Li L, Tang W, Xu W. Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment. J Biol Chem. 2022 Dec;298(12):102700. doi: 10.1016/j.jbc.2022.102700. © 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Donahue, Kristine; Xie, Haibo; Li, Miyang; Gao, Ang; Ma, Min; Wang, Yidan; Tipton, Rose; Semanik, Nicole; Primeau, Tina; Li, Shunqiang; Li, Lingjun; Tang, Weiping; and Xu, Wei, "Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment." Journal of Biological Chemistry. 298, 12. 102700 (2022).
https://digitalcommons.wustl.edu/oa_4/1695
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
